Atlas Trials

Effect of Aspergillus Niger Prolyl Endoprotease (AN-PEP) Enzyme on the Effects of Gluten Ingestion in Patients With Coeliac Disease

Clinical trial NCT00810654 · COMPLETED

Trial details

NCT number
NCT00810654
Sponsor
Amsterdam UMC, location VUmc
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Celiac Disease
Start date
2008-05-01
Primary completion
2009-05-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.